Oral Administration of Si-Based Agent Attenuates Oxidative Stress and Ischemia-Reperfusion Injury in a Rat Model: A Novel Hydrogen Administration Method.
Masataka Kawamura, Ryoichi Imamura, Yuki Kobayashi, Ayumu Taniguchi, Shigeaki Nakazawa, Taigo Kato, Tomoko Namba-Hamano, Toyofumi Abe, Motohide Uemura, Hikaru Kobayashi, Norio Nonomura · Frontiers in medicine · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In conclusion, renal IRI was attenuated by the oral administration of nano-Si, which should be considered as a novel H₂ administration method. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. In conclusion, renal IRI was attenuated by the oral administration of nano-Si, which should be considered as a novel H₂ administration method.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Before animal experiments, the researchers examined the hydrogen production from the agent containing 1.0 wt.% nano-Si particles and water using a sensor gas chromatograph, SGHA-P2-A (FIS Inc., Hyogo, Japan). The H₂ concentrations in blood samples were adjusted to the H₂ concentrations in air which fluctuated daily. In conclusion, renal IRI was attenuated by the oral administration of nano-Si, which should be considered as a novel H₂ administration method.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.